Phone: 1-617-401-8149
Fax: 1-617-606-5019
Email: message@sydlabs.com
Or leave a message with a formal purchase
order (PO) Or credit card.
Catalog No. | Product Name | Size | List Price (US$) | Quantity |
---|
Price/availability/specifications subject to change without notice. Unless otherwise indicated, our catalog and customized products are for research use only and not intended for human or animal diagnostic or therapeutic use.
Phone: 1-617-401-8149
Fax: 1-617-606-5019
Email: message@sydlabs.com
Or leave a message with a formal purchase
order (PO) Or credit card.
Background Information:
LOXO-101 (Larotrectinib) is an oral, potent and selective ATP-competitive pan-TRK inhibitor, with sub-nanomolar potency in IC50 values for all three TRK family members (TrkA, TrkB and TrkC), and >100-fold selectivity over other kinases. Displays robust in vitro and in vivo antitumor activities. It is currently in clinical evaluation.
APIM050183: LOXO-101 (LAROTRECTINIB)
CAS No.: 1223403-58-4.
Molecular Formula: C21H22F2N6O2?1/2H2O.
Molecular Weight: 437.4.
Purity: 99.9% chemical and stereomerical purity by achiral and chiral HPLCs.
QC: Achiral and Chiral HPLCs, 1H-NMR, and Elemental Analysis Report.
Solubility: Refer to certificate of analysis.
Storage: Refer to certificate of analysis.
Copyright © 2009-2022 sydlabs.com. All rights reserved.
Use of this website means that you have read, understood, and accepted the Syd Labs Privacy Policy and Terms & Conditions.